Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page shows a revision update from v3.6.2 to v3.6.3, indicating a minor system or documentation update. There are no visible changes to the page content or its purpose implied by this update.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page now shows an updated site revision, v3.6.2, replacing the previous v3.6.0. This reflects a small platform update rather than changes to the trial details or page structure.SummaryDifference0.0%

- Check38 days agoChange DetectedEnrollment status updated to 'No longer looking for participants', signaling recruitment closure. The update adds navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts labeling for Intervention/Treatment, with the site revision noted as v3.6.0.SummaryDifference0.3%

- Check45 days agoChange DetectedRevision metadata on the page was updated from v3.5.4 to v3.5.5, indicating a minor backend or template update rather than a content change.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a software version bump that updates internal/build metadata.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays Revision: v3.5.3 instead of Revision: v3.5.2, indicating a newer revision of the page metadata. This update does not affect the underlying content or its purpose.SummaryDifference0.0%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.